Skip to main content

News Archive

News Archive - School of Medicine

Participants in Dementia Prevention Research Motivated by Altruism

October 5, 2018

Researchers at University of California San Diego School of Medicine, with collaborators across the country, report that people who participate in dementia prevention trials are primarily motivated by altruism and pleased to help.

A New and Dire Diagnosis: Human Trafficking

October 4, 2018

Starting in the fall of 2018, UC San Diego Health will be the first health system in San Diego County to implement a policy ensuring that all mandatory reporters are responsible for reporting cases of suspected human trafficking. This policy will be a coordinated effort of administrative and professional staff at all points of entry into the health system.

Study Finds Human Milk Components in Amniotic Fluid

October 2, 2018

Human milk oligosaccharides (HMOs) are complex carbohydrates that are highly abundant and unique to human milk. Accumulating evidence indicates that exposure to HMOs in the postnatal period has both immediate and long-term benefits to infant health and development. Researchers at University of California San Diego School of Medicine report for the first time that HMOs are also present in amniotic fluid.

As Alzheimer’s Numbers Grow Among Latinos, Need for Research Grows Too, Say Experts

September 27, 2018

The National Institute on Aging has awarded scientists at University of California San Diego School of Medicine and San Diego State University with a five-year, $4 million grant to boost the number of Latino and other underrepresented minority researchers studying Alzheimer’s disease and related dementias afflicting seniors of Latino origins, a demographic historically overlooked.

Researchers Evaluate Controversial Treatment for Parkinson’s Disease Psychosis

September 26, 2018

In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson’s disease psychosis, researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system concluding that the new drug, pimavanserin (marketed as Nuplazid), did not pose a statistically significant greater risk of death.

For Cystic Fibrosis Lung Infections, How Well Antibiotics Work May be Affected by pH, Oxygen

September 26, 2018

In a study publishing September 26 in Science Advances, researchers at University of California San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences report that tweaking factors in a cystic fibrosis lung model, such as pH balance and oxygen, helped eradicate pathogenic bacteria while minimizing risks of antibiotic resistance and overgrowth of other microorganisms.

MyUCSDHealth App Available for Download on Apple and Android Mobile Devices

September 25, 2018

Access to world class care is now easier, faster and at the fingertips of UC San Diego Health patients and loved ones. With the new MyUCSDHealth mobile application, patients have the ability to manage their health information and communicate with their physicians while family members and friends can find helpful resources, such as visiting hours, directions and parking information.

Topping the Charts

September 24, 2018

More than 100 UC San Diego Health physicians have been named as “Top Docs” in the 2018 San Diego Magazine “Physicians of Exceptional Excellence” survey, an annual opportunity for doctors across the region to vote for much-admired colleagues.

Cancer Immunotherapy Might Benefit From Previously Overlooked Immune Players

September 20, 2018

Using a bioinformatics approach, University of California San Diego School of Medicine researchers found that CD4+ T cell’s binding partner, a molecule called MHC-II, may have even more influence on emerging tumors than MHC-I, the better known partner of CD8+ T cells. The finding, published September 20 in Cell, may help researchers improve cancer immunotherapies and predict which patients will respond best.

How Cells Repurpose their Garbage Disposal Systems to Promote Inflammation

September 18, 2018

Researchers at University of California San Diego School of Medicine have unraveled new insights into the way cells leverage G-protein-coupled receptors (GPCRs) and their cellular waste disposal systems to control inflammation. The findings, published September 18 in Cell Reports, suggest some existing cancer drugs that inhibit these cellular activities might be repurposed to treat vascular inflammation, which occurs when artery-blocking plaques form in atherosclerosis.
Category navigation with Social links